Written and maintained by CASRAI Editorial Board
Last updated
This guide is general information for supply, procurement and laboratory staff. It is not legal, regulatory or medical advice.
Short answer
Healthcare distribution is the set of wholesale channels that move pharmaceuticals, medical-surgical supplies and laboratory products from manufacturers to hospitals, pharmacies, clinics and labs. The channels are not regulated alike: prescription drugs fall under the federal Drug Supply Chain Security Act (DSCSA), while medical-surgical and laboratory products are mostly governed by contract terms plus product-specific rules.
Definition and scope
The Healthcare Distribution Alliance (HDA) describes itself as the national organization representing healthcare distributors, and describes distributors as the link between pharmaceutical manufacturers and pharmacies, hospitals and other sites of care (HDA, hda.org, checked 2026-11-01). “Healthcare distributors” and “pharmaceutical distributors” are therefore overlapping but not identical terms: a pharmaceutical distributor handles prescription and other drugs, while a healthcare distributor may also carry the medical-surgical and laboratory lines described below.
HDA states that about 450,000 providers, pharmacies and other sites of care use distributor services and that nearly 1,500 pharmaceutical manufacturers use them; HDA also claims savings of up to $78 billion annually. These are the association’s own undated figures, not independent measurements.
How healthcare distribution works in practice
For prescription drugs, FDA explains that the DSCSA outlines steps to build an interoperable, electronic way to identify and trace certain prescription drugs as they move through the U.S. supply chain. Its stated goals are to help prevent harmful drugs from entering the supply chain, to detect them if they do, and to enable rapid removal (FDA, DSCSA overview, page updated 2025-10-16, checked 2026-11-01). For what a wholesaler must do, see pharmaceutical wholesaler requirements and DSCSA compliance for distributors.
For medical-surgical supplies, the Health Industry Distributors Association (HIDA) Horizon Report on health-system supply chain strategies states that 90% of systems use a prime vendor distributor to acquire medical-surgical supplies and that 40% plan to increase the role medical-surgical distribution plays in their supply chain (HIDA, hida.org, checked 2026-11-01; the page is undated, and the figures come from an industry-association survey). The related buying structures are covered in hospital supply chain and group purchasing organizations.
The three channels compared
| Channel | What it moves | Rule or reference point (sourced) | Where to read more |
|---|---|---|---|
| Pharmaceutical distribution | Prescription drugs to pharmacies, hospitals and other sites of care | DSCSA tracing framework (FDA, checked 2026-11-01); HDA is the trade association for this channel | Pharmaceutical wholesaler, Good distribution practice |
| Medical-surgical (prime vendor) | Medical-surgical supplies to health systems | Per HIDA’s survey, 90% of systems use a prime vendor distributor; under 21 CFR 807.65 certain retail establishments making final delivery or sale to the ultimate user, and carriers, are exempt from device establishment registration (law.cornell.edu, checked 2026-08-30) | Medical supply wholesaler, Medical supply logistics |
| Laboratory products | Chemicals, reagents and consumables to labs | Under OSHA’s hazard communication standard, a laboratory employer that ships hazardous chemicals is a chemical manufacturer or distributor and owes shipped-container labels and safety data sheets (29 CFR 1910.1200(b)(3), osha.gov, checked 2026-08-26) | Vendor qualification process |
HDA versus HIDA
The two associations are easy to confuse. HDA describes distributors serving pharmaceutical manufacturers and sites of care; HIDA’s report on this page concerns medical-surgical distribution to health systems. Figures from one should not be applied to the other’s channel.
Where it matters for labs, clinics and supply decisions
A checklist of documents a buyer can request from a distributor, each tied to a page that explains it:
- Evidence of the distributor’s authorization to operate, for drug channels: see pharmaceutical wholesaler.
- Whether the distributor passes DSCSA transaction information for drugs: see DSCSA compliance for distributors.
- Storage and transport quality practices: see good distribution practice.
- Electronic shipping data such as advance ship notices: see EDI 856.
- Onboarding paperwork a vendor is asked for: see vendor onboarding documentation checklist.
This list routes to where each item is explained; it is not a regulatory requirement list, and which items apply depends on the channel and the product.
Common misunderstandings
- “Healthcare distributor” means drugs only. Drug distribution is one channel; medical-surgical and laboratory lines are distributed separately and are not covered by the DSCSA.
- Association statistics are regulatory data. HDA and HIDA figures are the associations’ own, undated statements.
- Distributors and group purchasing organizations are the same. A GPO negotiates contracts; a distributor fulfills orders. See group purchasing organization.
FAQ
What are healthcare distributors?
Wholesalers that supply pharmaceuticals, medical-surgical products or laboratory products to hospitals, pharmacies, clinics and labs. HDA calls distributors the link between manufacturers and sites of care.
What is a pharmaceutical distributor?
A distributor of prescription and related drugs. Prescription drugs moving through the U.S. supply chain are subject to the DSCSA tracing framework described by FDA.
Does the DSCSA cover medical supplies?
FDA describes the DSCSA as covering the tracing of certain prescription drugs, so it is not the framework for gloves, dressings or laboratory consumables.
Sources
- FDA, Drug Supply Chain Security Act (DSCSA), fda.gov, page updated 2025-10-16, checked 2026-11-01.
- Healthcare Distribution Alliance, hda.org, checked 2026-11-01.
- HIDA, Horizon Report: Health System Supply Chain Strategies, hida.org, checked 2026-11-01.
- 21 CFR 807.65, law.cornell.edu, checked 2026-08-30.
- OSHA, 29 CFR 1910.1200, osha.gov, checked 2026-08-26.
